Sr Director, Data Scientist at Gilead Sciences

Foster City, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, PharmaceuticalsIndustries

Requirements

Highly motivated individual with leadership experience suitable for Senior Director level
Ability to lead digital strategy, implementation roadmap, and cross-functional coordination
Expertise in supporting existing in silico tools and overseeing emerging technologies including AI
Experience championing data-driven, digitally empowered ways of working
Strong partnership skills with Technical Development leadership, IT, Manufacturing, CMC Regulatory, and broader Gilead digital ecosystem

Responsibilities

Continuously refine a Technical Development Digital Enablement roadmap aligned to organizational priorities and enterprise platforms
Translate Technical Development-specific digital needs into business cases for enterprise-level investments
Lead the business case development and ROI analysis for new digital investments, communicating trade-offs between speed, cost, and scope to leadership
In partnership with IT, identify, evaluate, and create strategic partnerships with technology providers to bring cutting-edge solutions
In partnership with key stakeholders, drive digital pilots and implementations
Foster relationships with internal partners (e.g., IT, CMC RA) and external vendors
Articulate a compelling vision for digital transformation within Technical Development
Leverage data science AI models to transform ways of working and accelerate development
Drive strategic data-centric solutions to enable drug development
Scan the digital landscape for emerging tools applicable to small molecule and biologics development
Lead change management, including upskilling, communication planning, and user adoption
Partner with broader Technical Development community to identify areas for digital innovation
Serve as a bridge between Technical Development and PDM digital governance groups
Represent Technical Development in PDM digital steering committees and structured content working groups
Align efforts with data governance, structured data initiatives, and broader PDM digital programs
Create a collaborative and inclusive work environment, promoting teamwork and effective communication
Lead, mentor, and develop the Data & Digital team

Skills

Data Science

Digital Strategy

In Silico Tools

Cross-Functional Coordination

Process Transformation

Emerging Technologies

Data-Driven Decision Making

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free